Genes involved in chromatin remodeling were also more frequently altered in IBC, such as EZH2 and SMARCA4, altered in 5% of IBC, providing a rationale for the evaluation of epigenetic modifiers for the treatment of IBC. The gene discussed is EZH2; the disease is inflammatory breast carcinoma.